Leerink Partners Upgrades Compass Therapeutics (CMPX) to Outperform
Tweet Send to a Friend
(Updated - April 2, 2025 6:49 AM EDT)
Leerink Partners analyst Andrew Berens upgraded Compass Therapeutics (NASDAQ: CMPX) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Leerink Partners analyst Andrew Berens upgraded Compass Therapeutics (NASDAQ: CMPX) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
